[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information to the Office of Management and Budget on a guidance on ...[ Price : $8.95]
Nanotherapeutics enrolls its first patient in a Phase 2 clinical trial of Triapine in combination with cisplatin and radiation in ...[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection on general licensing provisions for BLAs to the Office of Management an...[ Price : $8.95]
Federal Register Notice: FDA submits to the Office of Management and Budget a proposed collection of information on investigationa...[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information on premarket approval of medical devices to the Office o...[ Price : $8.95]
The Federal Trade Commission sues the owner of two companies marketing HCG diet products for deceptive advertising.[ Price : $8.95]
FDA approves label changes to GlaxoSmithKlines anti-seizure drug Potiga (ezogabine) to underscore risks of abnormalities to the re...[ Price : $8.95]
Washington Legal Foundation says it supports an earlier citizen petition criticizing the way FDA is changing the 510(k) program.